Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is an aggressive human cancer with increasing incidence worldwide. Multiple efforts have been made to explore pharmaceutical therapies to treat HCC, such as targeted tyrosine kinase inhibitors, immune based therapies and combination of chemotherapy. However, limitation...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Danyu, Liu, Chan, Qin, Mengyao, Zhang, Xiao, Xi, Tao, Yuan, Shengtao, Hao, Haiping, Xiong, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897153/
https://www.ncbi.nlm.nih.gov/pubmed/35256934
http://dx.doi.org/10.1016/j.apsb.2021.09.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897153/
https://www.ncbi.nlm.nih.gov/pubmed/35256934
http://dx.doi.org/10.1016/j.apsb.2021.09.019

Ejemplares similares